Click here to close Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly. We suggest using a current version of Chrome, FireFox, or Safari.
XB-IMG-74092

Xenbase Image ID: 74092

Fig. S2. Effects of the loss of Tbx2 function on expression of XC3H-3b and Vimentin. (A-H) Embryos injected with Tbx2 MO (10 ng) or Tbx2δC-GR (200 pg) were subjected to in situ hybridization for the markers XC3H-3b or Vimentin (shown for Tbx2 MO versus control in A,B) at stage 35 and then Vibratome sectioned (C-H). For the inducible Tbx2δC-GR construct, embryos were treated with dexamethasone from stage 22 to 35 (D,G) or left untreated (E,H). Left and right parts of each panel show the injected and uninjected sides of embryos, respectively. Brackets in C and D indicate the width of the pronephric duct. Dotted lines in F and G outline to the glomus domain. The expression of XC3H-3b and Vimentin was specifically detected around the pronephric nephron on the control side of embryos and these expression patterns were maintained around the pronephric nephron expanded by the depletion of Tbx2.

Image published in: Cho GS et al. (2011)

Copyright © 2011. Image reproduced with permission of the publisher and the copyright holder. This is an Open Access article distributed under the terms of the Creative Commons Attribution License.

GeneSynonymsSpeciesStage(s)Tissue
vim.Lvim-a, vim-b, vimentinX. laevisThroughout NF stage 35 and 36pronephric mesenchyme
zfp36l2.1.Sbrf2, c3h-4, C3H4, erf-2, erf2, rnf162c, tis11d, xC3H-4, zfp36l1, zfp36l4X. laevisThroughout NF stage 35 and 36pronephric mesenchyme

Image source: Published

Larger Image
Printer Friendly View

Return to previous page